Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates: implications for senolytic clinical trial design
Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
Combination of dasatinib and quercetin improves cognitive abilities in aged male Wistar rats, alleviates inflammation and changes hippocampal synaptic plasticity and histone H3 methylation profile
Deletion of SA β-Gal+ cells using senolytics improves muscle regeneration in old mice
Targeting p21Cip1 highly expressing cells in adipose tissue alleviates insulin resistance in obesity
Sexual dimorphic responses of C57BL/6 mice to Fisetin or Dasatinib and Quercetin cocktail oral treatment
A collective analysis of lifespan-extending compounds in diverse model organisms, and of species whose lifespan can be extended the most by the application of compounds
Modulation of fracture healing by the transient accumulation of senescent cells
Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
Dasatinib and Quercetin: Short-Term Simultaneous Administration Improves Physical Capacity in Humans
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells
https://meridian.allenpress.com/thij/article/50/5/e238262/496426/Targeting-Cell-Senescence-to-Improve-Cardiac
Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
%252Fdoc%252Fpsychiatry%252Falzheimers%252F2023-gonzales.pdf.html
Deletion of SA β-Gal+ cells using senolytics improves muscle regeneration in old mice
https%253A%252F%252Fonlinelibrary.wiley.com%252Fdoi%252F10.1111%252Facel.13528.html